Bristol Myers Squibb (BMY) Receivables - Other (2009 - 2026)
Bristol Myers Squibb (BMY) reported Receivables - Other of $149.0 million for Q1 2026, down 53.87% year-over-year from $323.0 million in Q1 2025, and down 22.4% on a QoQ basis from $192.0 million in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Receivables - Other data on file, last reported at $149.0 million in Q1 2026.
- Quarterly Receivables - Other fell 53.87% year-over-year to $149.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.0 million (down 53.87% YoY) and the FY2025 annual result came in at $192.0 million, down 88.93% from the prior year.
- Receivables - Other eased to $149.0 million in Q1 2026 per BMY's latest filing, from $192.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $2.0 billion in Q2 2023 and bottomed at $149.0 million in Q1 2026.
- The 5-year median for Receivables - Other is $504.0 million (2022), against an average of $903.9 million.
- The widest annual swing landed in 2024, when Receivables - Other soared 317.07%; it then tumbled 88.93% in 2025.
- Tracing BMY's Receivables - Other over 5 years: stood at $504.0 million in 2022, then decreased by 17.46% to $416.0 million in 2023, then surged by 317.07% to $1.7 billion in 2024, then tumbled by 88.93% to $192.0 million in 2025, then decreased by 22.4% to $149.0 million in 2026.
- Per Business Quant, the three latest BMY Receivables - Other figures stand at $149.0 million (Q1 2026), $192.0 million (Q4 2025), and $224.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.00 Mn |
| Mar 31, 2026 | 149.00 Mn |
| Dec 31, 2025 | 192.00 Mn |
| Dec 31, 2025 | 192.00 Mn |
| Sep 30, 2025 | 224.00 Mn |
| Sep 30, 2025 | 224.00 Mn |
| Jun 30, 2025 | 248.00 Mn |
| Jun 30, 2025 | 248.00 Mn |
| Mar 31, 2025 | 323.00 Mn |
| Mar 31, 2025 | 323.00 Mn |
| Dec 31, 2024 | 1.74 Bn |
| Dec 31, 2024 | 1.74 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 386.00 Mn |
| Jun 30, 2024 | 386.00 Mn |
| Mar 31, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 416.00 Mn |
| Dec 31, 2023 | 416.00 Mn |
| Sep 30, 2023 | 1.90 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.99 Bn |
| Mar 31, 2023 | 505.00 Mn |
| Mar 31, 2023 | 505.00 Mn |
| Dec 31, 2022 | 504.00 Mn |
| Dec 31, 2022 | 504.00 Mn |
| Sep 30, 2022 | 1.59 Bn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 410.00 Mn |
| Mar 31, 2022 | 410.00 Mn |
| Dec 31, 2021 | 1.39 Bn |
| Dec 31, 2021 | 1.39 Bn |
| Sep 30, 2021 | 1.37 Bn |
| Sep 30, 2021 | 1.37 Bn |
| Jun 30, 2021 | 1.30 Bn |
| Jun 30, 2021 | 1.30 Bn |
| Mar 31, 2021 | 1.47 Bn |
| Mar 31, 2021 | 1.47 Bn |
| Dec 31, 2020 | 254.00 Mn |
| Dec 31, 2020 | 254.00 Mn |
| Sep 30, 2020 | 1.29 Bn |
| Sep 30, 2020 | 1.29 Bn |
| Jun 30, 2020 | 1.16 Bn |
| Jun 30, 2020 | 1.16 Bn |
| Mar 31, 2020 | 1.09 Bn |
| Mar 31, 2020 | 1.09 Bn |
| Dec 31, 2019 | 1.21 Bn |
| Dec 31, 2019 | 1.21 Bn |
| Sep 30, 2019 | 1.06 Bn |
| Sep 30, 2019 | 1.06 Bn |
| Jun 30, 2019 | 998.00 Mn |
| Jun 30, 2019 | 998.00 Mn |
| Mar 31, 2019 | 952.00 Mn |
| Mar 31, 2019 | 952.00 Mn |
| Dec 31, 2018 | 1.11 Bn |
| Dec 31, 2018 | 1.11 Bn |
| Sep 30, 2018 | 1.07 Bn |
| Sep 30, 2018 | 1.07 Bn |
| Jun 30, 2018 | 1.07 Bn |
| Jun 30, 2018 | 1.07 Bn |
| Mar 31, 2018 | 984.00 Mn |
| Mar 31, 2018 | 984.00 Mn |
| Dec 31, 2017 | 940.00 Mn |
| Dec 31, 2017 | 940.00 Mn |
| Sep 30, 2017 | 378.00 Mn |
| Sep 30, 2017 | 378.00 Mn |
| Jun 30, 2017 | 369.00 Mn |
| Jun 30, 2017 | 369.00 Mn |
| Mar 31, 2017 | 271.00 Mn |
| Mar 31, 2017 | 271.00 Mn |
| Dec 31, 2016 | 239.00 Mn |
| Dec 31, 2016 | 239.00 Mn |
| Sep 30, 2016 | 255.00 Mn |
| Sep 30, 2016 | 255.00 Mn |
| Jun 30, 2016 | 267.00 Mn |
| Jun 30, 2016 | 267.00 Mn |
| Mar 31, 2016 | 274.00 Mn |
| Mar 31, 2016 | 274.00 Mn |
| Dec 31, 2015 | 211.00 Mn |
| Dec 31, 2015 | 211.00 Mn |
| Sep 30, 2015 | 181.00 Mn |
| Sep 30, 2015 | 181.00 Mn |
| Jun 30, 2015 | 145.00 Mn |
| Jun 30, 2015 | 145.00 Mn |
| Mar 31, 2015 | 134.00 Mn |
| Mar 31, 2015 | 134.00 Mn |
| Dec 31, 2014 | 224.00 Mn |
| Dec 31, 2014 | 224.00 Mn |
| Sep 30, 2014 | 293.00 Mn |
| Sep 30, 2014 | 293.00 Mn |
| Jun 30, 2014 | 193.00 Mn |
| Jun 30, 2014 | 193.00 Mn |
| Mar 31, 2014 | 196.00 Mn |
| Mar 31, 2014 | 196.00 Mn |
| Dec 31, 2013 | 286.00 Mn |
| Dec 31, 2013 | 286.00 Mn |
| Sep 30, 2013 | 280.00 Mn |
| Sep 30, 2013 | 280.00 Mn |
| Jun 30, 2013 | 183.00 Mn |
| Jun 30, 2013 | 183.00 Mn |
| Mar 31, 2013 | 205.00 Mn |
| Mar 31, 2013 | 205.00 Mn |
| Dec 31, 2012 | 199.00 Mn |
| Dec 31, 2012 | 199.00 Mn |
| Sep 30, 2012 | 198.00 Mn |
| Sep 30, 2012 | 198.00 Mn |
| Jun 30, 2012 | 183.00 Mn |
| Jun 30, 2012 | 183.00 Mn |
| Mar 31, 2012 | 179.00 Mn |
| Mar 31, 2012 | 179.00 Mn |
| Dec 31, 2011 | 156.00 Mn |
| Dec 31, 2011 | 156.00 Mn |
| Sep 30, 2011 | 160.00 Mn |
| Sep 30, 2011 | 160.00 Mn |
| Jun 30, 2011 | 203.00 Mn |
| Jun 30, 2011 | 203.00 Mn |
| Mar 31, 2011 | 203.00 Mn |
| Mar 31, 2011 | 203.00 Mn |
| Dec 31, 2010 | 196.00 Mn |
| Dec 31, 2010 | 196.00 Mn |
| Sep 30, 2010 | 264.00 Mn |
| Sep 30, 2010 | 264.00 Mn |
| Jun 30, 2010 | 227.00 Mn |
| Jun 30, 2010 | 227.00 Mn |
| Dec 31, 2009 | 294.00 Mn |
| Dec 31, 2009 | 294.00 Mn |